A new potential strategy for cutaneous squamous cell carcinoma treatment by generating serum-based antibodies from tumor-exposed mice - Liu, Zheng (eLife, 2024)
Keywords: Animals; Antibodies; Antibodies, Neoplasm - immunology; Antigens; Bcl-x protein; Biomarkers; Cancer Biology; cancer biomarkers; Cancer immunotherapy; Cancer therapies; Carcinoma, Squamous Cell - immunology; Carcinoma, Squamous Cell - therapy; Chemotherapy; Drug resistance; Enzyme-linked immunosorbent assay; Female; Immune system; immunotherapeutic strategy; Immunotherapy; Immunotherapy - methods; Mice; Microenvironments; mouse cutaneous squamous cell carcinoma; Mutation; NF-κB protein; p53 Protein; Proteins; Radiation therapy; serum-based antibodies; Skin Neoplasms - immunology; Skin Neoplasms - pathology; Skin Neoplasms - therapy; Squamous cell carcinoma; Thrombolytic drugs; Tumor cells; Tumor Suppressor Protein p53 - immunology; Tumor Suppressor Protein p53 - metabolism; Tumors; mouse; serum-based antibodies; cancer biology; cancer biomarkers; immunotherapeutic strategy; mouse cutaneous squamous cell carcinoma